|
肠道菌群通过影响胆汁酸代谢参与胆石症形成的研究进展
|
Abstract:
胆石症是一种常见的消化系统疾病,其主要特征是胆囊内形成结石。现有研究表明,胆囊结石(GSD)的发生发展涉及多重病理生理机制。流行病学调查显示,膳食结构异常、体质量指数超标等外源性因素与遗传易感性等内源性因素共同参与了疾病进程。从病理生理学角度分析,胆汁成分改变(如胆固醇过饱和状态)、胆囊动力学异常(包括收缩功能障碍和排空受阻)以及胆汁酸代谢紊乱等内在机制,构成了GSD形成的关键环节。这些因素相互作用,共同促进了胆固醇结晶的成核、生长和聚集。其流行病学特征在不同地区和人群中存在显著差异,影响其发病率的因素包括性别、年龄、种族和生活方式等。本文通过研究查阅国内外文献,综述了胆汁酸在肠道菌群对胆石症作用机制中的最新研究进展,包括肠道菌群对胆汁酸代谢的调控、胆汁酸代谢紊乱与胆石症的关系,本研究致力于深入探讨GSD的病理生理机制,通过系统分析其分子调控网络,识别关键作用靶点,进而开发创新性治疗策略。研究结果将为GSD的早期预防、临床治疗及预后改善提供理论依据和实践指导,推动该领域研究向纵深发展。
Gallstone disease (GSD) is a common digestive system disorder characterized by the formation of stones within the gallbladder. Current research indicates that the development of gallbladder stones involves multiple pathophysiological mechanisms. Epidemiological investigations reveal that both exogenous factors, such as abnormal dietary patterns and excessive body mass index, and endogenous factors, including genetic susceptibility, contribute to the disease process. From a pathophysiological perspective, intrinsic mechanisms such as alterations in bile composition (e.g., cholesterol supersaturation), gallbladder motility disorders (including impaired contractile function and obstructed emptying), and bile acid metabolism dysregulation constitute key components in the formation of GSD. These factors interact synergistically, collectively promoting the nucleation, growth, and aggregation of cholesterol crystals. Its epidemiological characteristics exhibit significant variations across different regions and populations, with factors influencing its incidence including gender, age, ethnicity, and lifestyle. This article reviews the latest research progress on the role of bile acids in the mechanism of gallstone disease mediated by gut microbiota by studying and referencing both domestic and international literature. This includes the regulation of bile acid metabolism by gut microbiota and the relationship between bile acid metabolism disorders and gallstone disease. This study aims to delve into the pathophysiological mechanisms of GSD, identify key targets through systematic analysis of its molecular regulatory network, and subsequently develop innovative therapeutic strategies. The research findings will provide a theoretical basis and practical guidance for the early prevention, clinical treatment, and prognosis improvement of GSD, driving the field's research towards greater depth and advancement.
[1] | 赵健楠, 刘洋, 王向, 等. 胆囊结石处理的临床决策: 从适应证到术式选择的再探索[J]. 中国普通外科杂志, 2025, 34(2): 245-252. |
[2] | Yang, T., Zhong, J., Zhang, R., Xiao, F., Wang, Y., Tao, H., et al. (2024) Different Types and Numbers Metabolic Abnormalities and Risk of Gallbladder Stone Disease in Adults. Frontiers in Nutrition, 11, Article ID: 1443575. https://doi.org/10.3389/fnut.2024.1443575 |
[3] | Rodriguez Gatta, D., Huidobro, L., Petermann-Rocha, F., Van de Wyngard, V., Godoy, F., Cid, V., et al. (2024) Sex Disparities in Gallstone Disease: Insights from the MAUCO Prospective Population-Based Cohort Study. BMJ Open Gastroenterology, 11, e001457. https://doi.org/10.1136/bmjgast-2024-001457 |
[4] | Teng, F., Tang, Y., Lu, Z., Chen, K. and Chen, Z. (2024) Investigating Causal Links between Gallstones, Cholecystectomy, and 33 Site-Specific Cancers: A Mendelian Randomization Post-Meta-Analysis Study. BMC Cancer, 24, Article No. 1192. https://doi.org/10.1186/s12885-024-12906-2 |
[5] | 阎良, 黄建平. 胆固醇结石的发病机制与治疗[J]. 中国中西医结合消化杂志, 2022, 30(9): 679-684. |
[6] | 赵瀚东, 高鹏, 詹丽. 肠道菌群及其代谢物在胆囊胆固醇结石形成中的作用机制[J]. 临床肝胆病杂志, 2022, 38(4): 947-950. |
[7] | Chen, J., Yan, L., Ma, X., Yuan, P., Zhao, F., Han, Z., et al. (2022) Alteration of Gut Microbiota in Type 2 Diabetes Complicated with Cholelithiasis Patients. Chinese Medical Journal, 135, 2125-2127. https://doi.org/10.1097/cm9.0000000000002102 |
[8] | Hu, H., Shao, W., Liu, Q., Liu, N., Wang, Q., Xu, J., et al. (2022) Gut Microbiota Promotes Cholesterol Gallstone Formation by Modulating Bile Acid Composition and Biliary Cholesterol Secretion. Nature Communications, 13, Article No. 252. https://doi.org/10.1038/s41467-021-27758-8 |
[9] | 孙晴晴, 刘胜兵, 王明月, 刘钰, 钱奕岑, 潘巍巍. 胆汁酸在肠黏膜屏障及相关肠道疾病中作用的研究进展[J]. 生理科学进展, 2024, 55(6): 568-574. |
[10] | Wang, Q., Lin, H., Shen, C., Zhang, M., Wang, X., Yuan, M., et al. (2023) Gut Microbiota Regulates Postprandial GLP-1 Response via Ileal Bile Acid-TGR5 Signaling. Gut Microbes, 15, Article ID: 2274124. https://doi.org/10.1080/19490976.2023.2274124 |
[11] | 吴振坤, 张先卓, 曹洁, 岳平, 孟文勃, 林延延. 消化道微生态与胆石症关系研究进展[J]. 中国微生态学杂志, 2023, 35(3): 366-369. |
[12] | 范妙言, 崔梦妍, 赵梦琦, 江巧丽, 陆颖影. 肠道菌群在胆石症及其防治中作用的研究进展[J]. 胃肠病学和肝病学杂志, 2024, 33(4): 432-435. |
[13] | 王强, 薛东波. 肠道菌群通过影响胆汁酸代谢参与胆囊胆固醇结石形成[J]. 肝胆胰外科杂志, 2020, 32(1): 6-8+25. |
[14] | 陈祯美, 林晶, 陈进宏. 《2021年日本胃肠病学会循证临床实践指南: 胆石症》意见要点[J]. 临床肝胆病杂志, 2023, 39(11): 2569-2574. |
[15] | 白烨. 胆石症病因网络的系统流行病学研究[D]: [博士学位论文]. 重庆: 重庆医科大学, 2023. |
[16] | Li, Y., Wang, L., Yi, Q., Luo, L. and Xiong, Y. (2024) Regulation of Bile Acids and Their Receptor FXR in Metabolic Diseases. Frontiers in Nutrition, 11, Article ID: 1447878. https://doi.org/10.3389/fnut.2024.1447878 |
[17] | 冯彬彬, 韩俊泉, 杨朝帅, 高天婴, 冉佳文, 王红. 基于“土壅木郁”理论探讨肠道菌群失调与胆固醇结石的相关性[J]. 北京中医药大学学报, 2023, 46(7): 980-984. |
[18] | 王素英, 闵莉. 从异病同治探讨肠道菌群对胆石症湿热病理的影响[J]. 中医药学报, 2022, 50(6): 1-5. |
[19] | Yoon, J., Do, J., Velankanni, P., Lee, C. and Kwon, H. (2023) Gut Microbial Metabolites on Host Immune Responses in Health and Disease. Immune Network, 23, e6. https://doi.org/10.4110/in.2023.23.e6 |
[20] | 程檬, 牛志强, 陈宗坤, 等. 肠道菌群与胆石症病因的研究进展[J]. 中国普通外科杂志, 2022, 31(8): 1113-1120. |
[21] | 罗欣, 成鹏, 陆茵, 韦忠红. 丁香酸调控胆汁酸代谢和肠道屏障改善胆汁淤积肝病的研究[J]. 南京中医药大学学报, 2024, 40(4): 350-358. |
[22] | 樊凤良, 孙海军. 肠道菌群与胆固醇结石、胆色素结石形成关系的研究进展[J]. 疑难病杂志, 2023, 22(8): 893-896. |
[23] | 蒋若云, 王玉. 肠道菌群代谢物胆汁酸与银屑病的研究进展[J]. 微生物学免疫学进展, 2024, 52(4): 96-100. |
[24] | 唐银佩, 朱正望, 朱平生, 等. 胆汁酸与肠道菌群互作在胆汁淤积发病和治疗中的作用[J]. 安徽医科大学学报, 2025(3): 578-583. |
[25] | 夏西茜, 丁珂珂, 张慧恒, 等. 肠道菌群介导胆汁酸影响炎症性肠病的研究进展[J]. 上海交通大学学报(医学版), 2024, 44(7): 839-846. |
[26] | 马先豪, 孙岩波, 岑云云, 等. 胆汁酸代谢对胆固醇结石形成影响的研究进展[J]. 肿瘤代谢与营养电子杂志, 2023, 10(3): 430-436. |
[27] | 叶绿望, 王丛, 范俊维, 等. 基于FXR-FGF19通路研究益生菌对胆总管结石患者胆汁酸代谢的影响[J]. 胃肠病学, 2024, 29(1): 10-14. |
[28] | 李茜荣, 寇小妮. 肠道菌群-胆汁酸轴在非酒精性脂肪肝病相关肝细胞癌中的研究进展[J]. 现代消化及介入诊疗, 2024, 29(6): 754-759. |
[29] | Yang, M., Massad, K., Kimchi, E.T., Staveley-O’Carroll, K.F. and Li, G. (2024) Gut Microbiota and Metabolite Interface-Mediated Hepatic Inflammation. Immunometabolism, 6, e00037. https://doi.org/10.1097/in9.0000000000000037 |
[30] | 王佳妮, 周殿友, 武丽娟. 肠道菌群在类风湿关节炎研究中的应用进展[J]. 河北医科大学学报, 2025, 46(2): 235-240. |
[31] | 宁雅倩, 秦文昊, 王慧丽, 杨档档, 林杉, 胡冰. 肠道菌群和机体免疫与胆石症关系的研究进展[J]. 胃肠病学, 2023, 28(5): 302-306. |
[32] | 滕金豪, 陈伟棠, 潘孟, 等. 胆石症的形成机制及外科治疗现状[J]. 安徽医科大学学报, 2024, 59(8): 1489-1494. |
[33] | Ye, X., Niu, X., Bai, D., Cao, Y., Mao, Y., Liu, H., et al. (2024) Comparison of Gallbladder Extraction via the Subxiphoid Port and the Supraumbilical Port during Laparoscopic Cholecystectomy: A Prospective Randomized Clinical Trial. International Journal of Surgery, 111, 628-634. https://doi.org/10.1097/js9.0000000000001932 |
[34] | 刘世洪, 李赣兵, 罗妍妍, 吴晶. 腹腔镜胆囊切除术联合胆舒胶囊在胆结石患者中的应用及对TNF-α IL-8及CRP的影响研究[J]. 基层医学论坛, 2025, 29(5): 5-8+12. |
[35] | 毛堂友, 姚树坤, 白宇宁, 谢春娥, 李晓红, 李军祥. 胆石症中西医结合诊疗专家共识(2025年) [J]. 中国中西医结合消化杂志, 2025, 33(3): 242-251. |
[36] | 陈静, 何洁, 陈江慧, 等. 瘦素基因G2548A多态性及环境因素与胆囊胆固醇结石关联性研究[J]. 四川大学学报(医学版), 2017, 48(3): 410-417. |
[37] | 彭晓飞, 吴红伟, 张小文. 胆汁中的瘦素与胆结石的形成[J]. 医学综述, 2009, 15(17): 2570-2571. |
[38] | 陈轶昀, 陈琛, 吴科能. 胆结石的化学基础研究进展[J]. 中国社区医师, 2014, 30(18): 7-8. |
[39] | 何静宇, 温剑, 杨闯, 张永川. 瘦素调节胆汁酸代谢影响胆石形成[J]. 基础医学与临床, 2019, 39(12): 1723-1728. |
[40] | 杨永, 杨连招, 莫新少. 胆结石并胆道感染菌群与术后胆红素变化规律的护理研究[J]. 护理研究, 2012, 26(25): 2361-2363. |
[41] | 王坤, 葛春林. 胆汁成分改变及其相关疾病研究进展[J]. 中国医学工程, 2012, 20(7): 187-188. |
[42] | Wang, T., Xie, R., Jiang, C. and Chen, L. (2024) Associations between Life’s Essential 8 and Gallstones among US Adults: A Cross-Sectional Study from NHANES 2017-2018. PLOS ONE, 19, e0312857. https://doi.org/10.1371/journal.pone.0312857 |
[43] | Yuan, S., Lu, Y., Xiao, Z. and Ma, S. (2025) Body Mass Index Mediates the Relationship between Estimated Glucose Disposal Rate and Gallstones. Scientific Reports, 15, Article No. 2214. https://doi.org/10.1038/s41598-025-86708-2 |
[44] | 邵苗苗, 王玉丽, 李婉婷, 赵睿, 孙凯隆, 王毓麟. 基于“阳化气, 阴成形”探讨胆石症的中医病机及治疗思路[J]. 亚太传统医药, 2024, 20(11): 103-106. |
[45] | 潘志明. 50例中医排石汤药治疗胆结石的临床效果[J]. 内蒙古中医药, 2014, 33(27): 36. |